OKYO Pharma Limited (OKYO)
NASDAQ
OKYO price, last 12 months
Key stats
- Previous close
- $1.10
- Open
- $1.12
- Day range
- $1.00 – $1.18
- 52-week range
- $1.00 – $3.20
- Volume
- 752.4K
- Avg volume (20 days)
- 304.2K
- Market cap
- $70.8M
Performance
Technicals and fundamentals
About OKYO Pharma Limited
OKYO Pharma Ltd is a clinical-stage ophthalmology company focused on developing differentiated therapies for corneal and anterior segment diseases. It is advancing a pipeline designed to improve outcomes for patients suffering from debilitating ocular diseases that impact vision and ocular comfort. The company's main program, urcosimod, is being developed as a potential treatment for neuropathic corneal pain. Additionally, its development pipeline includes an exploratory candidate, OK-201, a non-opioid analgesic drug candidate, as a potential drug to treat acute and chronic ocular pain. The company has only one operating segment: the research and development of biotechnological and pharmaceutical products.
- Listed on
- NASDAQ
- Market cap
- $70.8M